ANAVEX LIFE SCIENCES CORP. Increase (Decrease) in Accrued Liabilities
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Increase (Decrease) in Accrued Liabilities of -$661.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$503.00K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $807.00K, a 55.73% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$965.00K, a 133.31% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$37.00K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accrued liabilities for fiscal 2025 was -$943.00K.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accrued liabilities for fiscal 2024 was -$2.46M, a 282.22% decline from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accrued liabilities for fiscal 2023 was $1.35M, a 309.09% increase from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. increase (decrease) in accrued liabilities for fiscal 2022 was $330.00K, a 85.64% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$503.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-28 | $304.00K derived: sum of 2 quarters · filed 2026-08-28 | -$661.00K 10-Q · filed 2026-08-28 | -$698.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | $807.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-28 | -$158.00K 10-Q · filed 2026-08-28 | -$195.00K derived: sum of 3 quarters · filed 2026-08-28 | -$5.82M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | -$965.00K 10-Q · filed 2026-02-09 | -$1.00M derived: sum of 2 quarters · filed 2026-08-28 | -$6.63M derived: sum of 3 quarters · filed 2026-08-28 | -$4.80M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | -$37.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$5.66M derived: sum of 2 quarters · filed 2026-08-28 | -$3.84M derived: sum of 3 quarters · filed 2026-08-28 | -$943.00K 10-K/A · filed 2026-08-28 | ||||
| 2025-06-30 | -$5.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-28 | -$3.80M derived: sum of 2 quarters · filed 2026-08-28 | -$906.00K 10-Q · filed 2026-08-28 | -$3.40M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-28 | $4.72M 10-Q · filed 2026-08-28 | $2.22M derived: sum of 3 quarters · filed 2026-08-28 | $4.64M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | $2.90M 10-Q · filed 2026-02-09 | $398.00K derived: sum of 2 quarters · filed 2026-08-28 | $2.82M derived: sum of 3 quarters · filed 2026-08-28 | $446.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-09-30 | -$2.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | -$80.00K derived: sum of 2 quarters · filed 2026-08-28 | -$2.45M derived: sum of 3 quarters · filed 2026-08-28 | -$2.46M 10-K/A · filed 2026-08-28 | ||||
| 2024-06-30 | $2.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | $48.00K derived: sum of 2 quarters · filed 2025-08-12 | $39.00K 10-Q · filed 2025-08-12 | $1.35M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-03-31 | -$2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-13 | -$2.38M 10-Q · filed 2025-05-13 | -$1.07M derived: sum of 3 quarters · filed 2026-08-28 | -$1.91M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-12-31 | -$9.00K 10-Q · filed 2025-02-12 | $1.30M derived: sum of 2 quarters · filed 2026-08-28 | $463.00K derived: sum of 3 quarters · filed 2026-08-28 | $243.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2023-09-30 | $1.31M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $472.00K derived: sum of 2 quarters · filed 2026-08-28 | $252.00K derived: sum of 3 quarters · filed 2026-08-28 | $1.35M 10-K/A · filed 2026-08-28 | ||||
| 2023-06-30 | -$837.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-06 | -$1.06M derived: sum of 2 quarters · filed 2024-08-06 | $41.00K 10-Q · filed 2024-08-06 | $40.70K 10-Q · filed 2023-08-08 | $71.95K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $878.00K 10-Q · filed 2024-05-09 | $877.88K 10-Q · filed 2023-05-09 | $908.95K derived: sum of 3 quarters · filed 2024-05-09 | $1.83M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $1.10M 10-Q · filed 2024-02-07 | $1.10M 10-Q · filed 2023-02-07 | $1.13M derived: sum of 2 quarters · filed 2024-02-07 | $2.05M derived: sum of 3 quarters · filed 2024-02-07 | $1.59M derived: sum of 4 quarters · filed 2024-02-07 | |||
| 2022-09-30 | $30.95K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $949.39K derived: sum of 2 quarters · filed 2023-11-27 | $494.73K derived: sum of 3 quarters · filed 2023-11-27 | $330.00K 10-K · filed 2023-11-27 | $330.18K 10-K · filed 2022-11-28 | |||
| 2022-06-30 | $918.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $463.78K derived: sum of 2 quarters · filed 2023-08-08 | $299.05K 10-Q · filed 2023-08-08 | $1.26M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2022-03-31 | -$454.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | -$619.39K 10-Q · filed 2023-05-09 | $341.95K derived: sum of 3 quarters · filed 2023-11-27 | $1.38M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-12-31 | -$164.73K 10-Q · filed 2023-02-07 | $796.61K derived: sum of 2 quarters · filed 2023-11-27 | $1.83M derived: sum of 3 quarters · filed 2023-11-27 | $1.63M derived: sum of 4 quarters · filed 2023-11-27 | ||||
| 2021-09-30 | $961.34K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-27 | $2.00M derived: sum of 2 quarters · filed 2023-11-27 | $1.80M derived: sum of 3 quarters · filed 2023-11-27 | $2.30M 10-K · filed 2023-11-27 | $2.30M 10-K · filed 2021-11-24 | |||
| 2021-06-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-09 | $836.71K derived: sum of 2 quarters · filed 2022-08-09 | $1.34M 10-Q · filed 2022-08-09 | $1.68M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | -$197.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | $302.20K 10-Q · filed 2022-05-10 | $649.78K derived: sum of 3 quarters · filed 2022-11-28 | $1.04M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | $499.95K 10-Q · filed 2022-02-09 | $847.53K derived: sum of 2 quarters · filed 2022-11-28 | $1.24M derived: sum of 3 quarters · filed 2022-11-28 | $1.48M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | $347.58K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $737.48K derived: sum of 2 quarters · filed 2022-11-28 | $980.15K derived: sum of 3 quarters · filed 2022-11-28 | $1.80M 10-K · filed 2022-11-28 | ||||
| 2020-06-30 | $389.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $632.58K derived: sum of 2 quarters · filed 2021-08-12 | $1.45M 10-Q · filed 2021-08-12 | $1.85M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $242.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | $1.06M 10-Q · filed 2021-05-13 | $1.46M derived: sum of 3 quarters · filed 2021-05-13 | $1.60M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $820.08K 10-Q · filed 2021-02-16 | $1.22M derived: sum of 2 quarters · filed 2021-02-16 | $1.36M derived: sum of 3 quarters · filed 2021-02-16 | $1.50M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | $402.09K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $535.66K derived: sum of 2 quarters · filed 2020-12-28 | $679.27K derived: sum of 3 quarters · filed 2020-12-28 | $587.01K 10-K · filed 2020-12-28 | ||||
| 2019-06-30 | $133.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | $277.18K derived: sum of 2 quarters · filed 2020-08-06 | $184.92K 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | $143.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $51.34K 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | -$92.26K 10-Q · filed 2020-02-06 | |||||||
| 2018-09-30 | $262.06K 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |